• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


108.2500 SEK 0.7500 0.69%

As of 11:02:17 ET on 04/17/2014.

Snapshot for Medivir AB (MVIRB)

Open: 109.0000 Day's Range: 108.0000 - 109.2500 Volume: 51,903
Previous Close: 109.0000 52wk Range: 63.0000 - 121.0000 1-Yr Rtn: +39.68%

Stock Chart for MVIRB

No chart data available.
  • MVIRB:SS 108.2500
  • 1D
  • 1M
  • 1Y
Interactive MVIRB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVIRB

Current P/E Ratio (ttm) 150.3953
Estimated P/E(12/2014) 14.3340
Relative P/E vs. OMX 8.8679
Earnings Per Share (SEK) (ttm) 0.7198
Est. EPS (SEK) (12/2014) 7.5520
Est. PEG Ratio -
Market Cap (M SEK) 3,383.90
Shares Outstanding (M) 30.60
30 Day Average Volume 252,701
Price/Book (mrq) 3.9689
Price/Sale (ttm) 6.1458
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVIRB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVIRB

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Maris HartmanisPresident/CEOChristina KassbergExec VP:Finance & Administration
Paul WallaceExec VP:Business DevelopmentRein PiirExec VP:Corporate Affairs
More Company Profile & Key Executives for MVIRB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil